Results 11 to 20 of about 30,740 (199)

Neuroendocrine Tumours: a Literature Review

Креативная хирургия и онкология, 2021
Neuroendocrine tumours (NETs) are a heterogeneous group of malignant neoplasms with diverse morphology and nomenclature. Well-differentiated NETs were historically termed carcinoid tumours, which entailed abundant confusion and misclassification.
K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, A. F. Nasretdinov, N. I. Sultanbaeva, I. R. Shaykhutdinov   +6 more
doaj   +1 more source

Diabetes Insipidus Induced by Combination of Short-acting Ocreotide and Lanreotide for Recurrent Carcinoid Crisis of Neuroendocrine Tumour

Journal of the ASEAN Federation of Endocrine Societies, 2022
Somatostatin analogue is useful in carcinoid crisis for symptom control. Optimal dosing of somatostatin analogues for carcinoid symptoms is not known. This case highlighted management issues using combination short-acting octreotide infusion with long ...
Goh Kian Guan, Subashini Rajoo, Noraini Mohd Dusa, Nik Hasimah Nik Yahya, Mohamed Badrulnizam Long Bidin   +4 more
doaj   +1 more source

Aspects of classification and diagnostic search for transient and persistent facial erythema

Лечащий Врач, 2021
Rosacea is one of the most common conditions on the face. Rosacea affecting the central parts of the face and is characterized by erythema, flushing, telangiectasia; papules and pustules.
T. А. Sysoeva, I. Е. Frolova, E. К. Murakhovskaya, A. S. Bisharova, I. B. Mertsalova   +4 more
doaj   +1 more source

Carcinoid heart disease: A case discussion with reappraisalcarcinoid heart disease: A case discussion with reappraisal

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2017
Carcinoid tumors are malignant neuroendocrine tumors arising from Kulchitsky cell. The most common site of primary carcinoid tumors is gastrointestinal tract (64%) followed by respiratory tract (28%).
Rohit Tandon, Ravinder Pal Singh
doaj   +1 more source

Ectopic corticotroph syndrome [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2004
INTRODUCTION Endogenous Cushing's syndrome is a clinical state resulting from prolonged, inappropriate exposure to excessive endogenous secretion of Cortisol and hence excess circulating free cortisol, characterized by loss of the normal feedback ...
Penezić Zorana, Savić Slavica, Vujović Svetlana, Tatić Svetislav B., Ercegovac Maja, Drezgić Milka   +5 more
doaj   +1 more source

Hedinger Syndrome—Lessons Learnt: A Single-Center Experience

Journal of Cardiovascular Development and Disease, 2023
Background: Hedinger syndrome (HS) or carcinoid heart disease (CD) is a rare and challenging manifestation of malignant neuroendocrine tumours (NETs) involving the heart.
Mohamed El Gabry, Sven Arends, Sharaf-Eldin Shehada, Harald Lahner, Markus Kamler, Daniel Wendt, Konstantina Spetsotaki   +6 more
doaj   +1 more source

A novel mutation of the MEN1 gene in a patient with multiple endocrine neoplasia type 1 and recurrent fibromyxoid sarcoma – a case report

BMC Medical Genetics, 2020
Background Multiple endocrine neoplasia type 1 (MEN1) syndrome is usually accompanied by endocrine tumors, but non-endocrine tumors can occur as well. However, the coexistence of MEN1 syndrome and malignant tumor such as low-grade fibromyxoid sarcoma has
Maja Radman, Tanja Milicevic
doaj   +1 more source

Primary carcinoid tumors at atypical sites: surgery is mandatory and size determines survival—an Egyptian study

Bulletin of the National Research Centre, 2019
Background Carcinoids at atypical sites are rare and mostly asymptomatic. In the majority, they show normal levels of serotonin and its metabolites in plasma and urine, resulting in a relatively late diagnosis and hence guarded prognosis.
Karim G. Moustafa, Gamal M. Saied
doaj   +1 more source

Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1

Frontiers in Endocrinology, 2023
Cushing’s syndrome (CS) resulting from endogenous hypercortisolism can be sporadic or can occur in the context of familial disease because of pituitary or extra-pituitary neuroendocrine tumors.
William F. Simonds
doaj   +1 more source

High-Dose Lanreotide in the Treatment of Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: A Case Report

Case Reports in Oncology, 2014
Pancreatic neuroendocrine tumors (NETs), including poorly differentiated carcinomas (NECs), are rarely encountered. The majority of these tumors do not secrete excess hormones, but functioning NETs produce large amounts of vasoactive peptides and may ...
Frank Van Fraeyenhove, Nathalie Meireson, Luc Terriere, Paul Willemsen, Jan Kunnen, Caroline Mattelaer, Frank Van Acker, Dirk Schrijvers   +7 more
doaj   +1 more source